Article Details

Zacks Investment Research Downgrades ChromaDex (NASDAQ:CDXC) to Sell

Retrieved on: 2021-03-16 11:45:00

Tags for this article:

Click the tags to see associated articles and topics

Zacks Investment Research Downgrades ChromaDex (NASDAQ:CDXC) to Sell. View article details on hiswai:

Excerpt

Renaissance Technologies LLC now owns 235,200 shares of the company's stock worth $1,129,000 after buying an additional 153,819 shares in the ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up